Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 23.71
-0.04 (-0.17%)
Oct 9, 2026, 3:04 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 20.94 billion as of October 9, 2026. It is the 5,086th most valuable company in the world and the 830th biggest in China. Its market cap has increased by 11.16% in one year.
Market Cap
20.94B
Enterprise Value
22.72B
Revenue
1.11B
Global Rank
Country Rank
#830 China
PE Ratio
166.60
ChartMarket Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 20.94B, an increase of 614.73%. That is a compound annual growth rate of 13.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 20.94B | 32.46% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.69B |
| Livzon Pharmaceutical Group | 22.98B |
| Walvax Biotechnology | 22.52B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.19B |
| Tasly Pharmaceutical Group | 20.93B |
| Jilin Aodong Pharmaceutical Group | 20.24B |
| Betta Pharmaceuticals | 20.13B |
| Shanghai Haoyuan Chemexpress | 20.08B |